|
"jia horng kao"的相關文件
顯示項目 861-870 / 1180 (共118頁)
<< < 82 83 84 85 86 87 88 89 90 91 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T14:50:44Z |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Lin, Y.-H.; Hwang, R.-M.; Chen, B.-B.; Hsu, C.-Y.; Yu, C.-W.; Kao, J.-H.; Lee, H.-S.; Liang, P.-C.; Wei, S.-Y.; Shih, T.T.F.; Lin, Yen-Heng; Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Kao, Jia-Horng; Lee, Hsuan-Shu; Liang, Po-Chin; Shih, Tiffany Ting-Fang; Shih, Tiffany Ting-Fang;Shih, Tiffany Ting-Fang;Wei, Shwu-Yuan;Wei, Shwu-Yuan;Liang, Po-Chin;Liang, Po-Chin;JIA-HORNG KAO;Lee, Hsuan-Shu;Lee, Hsuan-Shu;CHIH-WEI YU;BANG-BIN CHEN;Kao, Jia-Horng;Kao, Jia-Horng;Yu, Chih-Wei;Yu, Chih-Wei;CHAO-YU HSU;Hsu, Chao-Yu;Hsu, Chao-Yu;HSUAN-SHU LEE;Chen, Bang-Bin;PO-CHIN LIANG;Chen, Bang-Bin;Hwang, Ruey-Ming;YEN-HENG LIN;Hwang, Ruey-Ming;Lin, Yen-Heng;TIFFANY TING-FANG SHIH;Lin, Yen-Heng;Shih, T.T.F.;Wei, S.-Y.;Liang, P.-C.;Lee, H.-S.;Kao, J.-H.;Yu, C.-W.;Hsu, C.-Y.;Chen, B.-B.;Hwang, R.-M.;Lin, Y.-H. |
| 臺大學術典藏 |
2018-09-10T14:50:43Z |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Liang, P.-C.; Wei, S.-Y.; Hwang, R.-M.; Shih, T.T.-F.; TIFFANY TING-FANG SHIH; PO-CHIN LIANG; HSUAN-SHU LEE; CHAO-YU HSU; Lee, H. -S.; BANG-BIN CHEN; CHIH-WEI YU; JIA-HORNG KAO; Shih, T. T. -F.;Hwang, R. -M.;Wei, S. -Y.;JIA-HORNG KAO;Liang, P. -C.;CHIH-WEI YU;BANG-BIN CHEN;Lee, H. -S.;CHAO-YU HSU;Kao, J. -H.;Yu, C. -W.;HSUAN-SHU LEE;PO-CHIN LIANG;Hsu, C. -Y.;TIFFANY TING-FANG SHIH;Chen, B. -B.;Shih, T.T.-F.;Hwang, R.-M.;Wei, S.-Y.;Liang, P.-C.;Lee, H.-S.;Kao, J.-H.;Yu, C.-W.;Hsu, C.-Y.;Chen, B.-B.; Chen, B.-B.; Hsu, C.-Y.; Yu, C.-W.; Kao, J.-H.; Lee, H.-S. |
| 臺大學術典藏 |
2018-09-10T14:50:43Z |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Liang, P.-C.; Wei, S.-Y.; Hwang, R.-M.; Shih, T.T.-F.; TIFFANY TING-FANG SHIH; PO-CHIN LIANG; HSUAN-SHU LEE; CHAO-YU HSU; Lee, H. -S.; BANG-BIN CHEN; CHIH-WEI YU; JIA-HORNG KAO; Shih, T. T. -F.;Hwang, R. -M.;Wei, S. -Y.;JIA-HORNG KAO;Liang, P. -C.;CHIH-WEI YU;BANG-BIN CHEN;Lee, H. -S.;CHAO-YU HSU;Kao, J. -H.;Yu, C. -W.;HSUAN-SHU LEE;PO-CHIN LIANG;Hsu, C. -Y.;TIFFANY TING-FANG SHIH;Chen, B. -B.;Shih, T.T.-F.;Hwang, R.-M.;Wei, S.-Y.;Liang, P.-C.;Lee, H.-S.;Kao, J.-H.;Yu, C.-W.;Hsu, C.-Y.;Chen, B.-B.; Chen, B.-B.; Hsu, C.-Y.; Yu, C.-W.; Kao, J.-H.; Lee, H.-S. |
| 臺大學術典藏 |
2018-09-10T14:50:10Z |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin;Kao, Jia-Horng;Chen, Ting-Chih;Wu, Wen-Hsuan;Liu, Chen-Hua;Su, Tung-Hung;Yang, Hung-Chih;Chen, Ding-Shinn;Chen, Pei-Jer;Liu, Chun-Jen; Wu, H.-L. and Kao, J.-H. and Chen, T.-C. and Wu, W.-H. and Liu, C.-H. and Su, T.-H. and Yang, H.-C. and Chen, D.-S. and Chen, P.-J. and Liu, C.-J.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; Wu, Hui-Lin; HUNG-CHIH YANG; Kao, Jia-Horng; CHUN-JEN LIU; Kao, Jia-Horng; PEI-JER CHEN; Chen, Ting-Chih; Chang, Julia Yu-Fong; CHEN-HUA LIU; Wu, Wen-Hsuan; Liu, Chen-Hua; TUNG-HUNG SU; Liu, Chen-Hua; Su, Tung-Hung; DING-SHINN CHEN; Su, Tung-Hung; JIA-HORNG KAO; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Chen, Pei-Jer; Liu, Chun-Jen; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:50:07Z |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.
|
Chen, Ming-Yao;Liu, Chen-Hua;Chen, Ting-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng;Liu, Chun-Jen; 陳定信;高嘉宏;劉俊人;陳培哲; Chen, Ming-Yao; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Chen, Ting-Chih; Su, Tung-Hung; TUNG-HUNG SU; Chang, Wen-Hsiung; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; JIA-HORNG KAO; Kao, Jia-Horng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:50:07Z |
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.
|
Liu, Chen-Hua;Kao, Jia-Horng; Liu, Chen-Hua; CHEN-HUA LIU; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
|
Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Tsai, Pei-Shan; Polis, Michael Alan; JIA-HORNG KAO; Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Kao, Jia-Horng; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Fan, Yen-Chun; Tsai, Pei-Shan; Tsai, Pei-Shan; Polis, Michael Alan |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan
|
Hsu, C.-S.;Kao, J.-H.;Chao, Y.-C.;Lin, H.H.;Fan, Y.-C.;Huang, C.-J.;Tsai, P.-S.; Hsu, C-S; JIA-HORNG KAO; Kao, J-H; Kao, J-H; Chao, Y-C; Lin, H. H.; Lin, H. H.; Fan, Y-C; Fan, Y-C; Huang, C-J; Huang, C-J; Tsai, P-S |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua |
顯示項目 861-870 / 1180 (共118頁)
<< < 82 83 84 85 86 87 88 89 90 91 > >>
每頁顯示[10|25|50]項目
|
